GlassScriptPhysician profile
Mayya Munarova
NPI 1770520579
$1,738.43
in general payments reported to CMS, 2019-2025
23 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $222 · 2021: $141 · 2022: $119 · 2023: $374 · 2024: $224 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.52 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.36 | 2019-2025 | |
| Coopersurgical, INC. | $196.86 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Lupin INC. | $186.08 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $159.08 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $140.84 | 2019-2021 | |
| Biogen, INC. | $111.33 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $106.00 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $99.35 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $80.40 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $73.82 | 2023-2025 | |
| Shield Therapeutics INC | $63.50 | 2023 | Accrufer |
| Scynexis, INC. | $44.99 | 2022 | |
| Pfizer INC. | $39.13 | 2023-2024 | |
| Mission Pharmacal Company | $31.79 | 2019 | |
| Daiichi Sankyo INC. | $31.71 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $23.58 | 2025 | Cholbam |
| Duchesnay USA Incorporated | $20.52 | 2019 | |
| Genzyme Corporation | $17.90 | 2023 | |
| Roche Diagnostics Corporation | $16.53 | 2019 | |
| Avion Pharmaceuticals | $16.33 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.17 | 2022 | |
| Dysis Medical, INC. | $13.56 | 2022 | |
| Therapeuticsmd, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayya Munarova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.